Endotis reports the successful completion of Phase I clinical trials of neutralizable anticoagulant EP217609 and antidote avidin
03-May-2010
- France
Organizations
Endotis Pharma
ALIZE
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.